comparemela.com

Latest Breaking News On - Israeli institute for biological research - Page 2 : comparemela.com

Dr Morris C Laster Files Preliminary Proxy Statement Nominating Two Highly-Qualified Individuals For Election To Board At Scopus BioPharma Inc s 2021 Annual Meeting

Dr Morris C Laster Files Preliminary Proxy Statement Nominating Two Highly-Qualified Individuals For Election To Board At Scopus BioPharma Inc s 2021 Annual Meeting
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Dr Morris C Laster Files Preliminary Proxy Statement Nominating Two Highly-Qualified Individuals For Election To Board At Scopus BioPharma Inc s 2021 Annual Meeting

Dr Morris C Laster Files Preliminary Proxy Statement Nominating Two Highly-Qualified Individuals For Election To Board At Scopus BioPharma Inc s 2021 Annual Meeting
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Israel developed mask proves 99 9pc effective against corona

National December 20, 2020 ISLAMABAD: Israeli Prof Zeev Rotstein has been in isolation since last week after four passengers on his El Al flight from Dubai to Israel tested positive for coronavirus. But, Rotstein, the head of Hadassah-University Medical Centre told Israeli media that he does not believe he can be infected by the virus because he was wearing a Health Ministry-approved mask that repels and even decomposes biological materials. The mask, developed by the Israeli Institute for Biological Research – the same institute that is developing Brilife, Israel’s coronavirus vaccine together with Hadassah and the start-up Tera Novel, is a surgical face mask with active anti-viral and anti-bacterial protection. It has been shown to be 99.999 percent effective against corona, the hospital said.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.